C&N HOLDING
The computed 12-month bankruptcy probability of C&N HOLDING is 0.1% (very low). The 2024 annual accounts show equity of €5.46M and a net result of €5.46M. Equity is growing by ~3% per year across the filed fiscal years. Its solvency ranks better than 75% of 1398 sector peers (fiscal year 2024). The company has been active since 2004 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €5.46M |
| Net result | €5.46M |
| Better than sector | 75% |
| Active | 22 yrs |
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 69.9% | 43.5% | |
| Net result | €5.46M | €42k | |
| Equity | €5.46M | €163k | |
| Gross operating margin | €129k | €72k | |
| Employees (FTE) | 0.0 | 0.0 |
Show 11 other metrics
| Fiscal year | 2024 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | €108k |
| Net profit | €5.46M |
| Cash flow | €5.53M |
| Staff costs | - |
| Income taxes | €544k |
| Dividends | €88k |
| Total assets | €7.81M |
| Equity | €5.46M |
| Debt | €2.35M |
| of which ≤ 1y | €1.58M |
| of which > 1y | €768k |
| Working capital | €5.14M |
| Employees (FTE) | 0.0 |
| 2024 | |
|---|---|
| Current ratio | 4.25 |
| Quick ratio | 4.25 |
| Working capital ratio | 65.8% |
| Solvency | 69.9% |
| Debt / equity | 0.43 |
| Long-term debt ratio | 0.14 |
| Interest coverage | 2.59 |
| Gross margin | - |
| Net margin | - |
| ROA | 69.9% |
| ROE | 100.1% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (24 line items)
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €7.81M |
| Fixed assets | 21/28 | €1.09M |
| Tangible fixed assets | 22/27 | €241k |
| Financial fixed assets | 28 | €848k |
| Current assets | 29/58 | €6.72M |
| Amounts receivable within one year | 40/41 | €30k |
| Cash & bank | 54/58 | €32k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €7.81M |
| Equity | 10/15 | €5.46M |
| Contributions / capital | 10/11 | €10k |
| Reserves | 13 | €5.45M |
| Accumulated profits (losses) | 14 | €0 |
| Amounts payable | 17/49 | €2.35M |
| Amounts payable after one year | 17 | €768k |
| Amounts payable within one year | 42/48 | €1.58M |
| Trade debts payable within one year | 44 | €2k |
| Income statement | ||
| Gross operating margin | 9900 | €129k |
| Operating result | 9901 | €41k |
| Financial income | 75 | €7k |
| Financial charges | 65 | €42k |
| Result before taxes | 9903 | €6.01M |
| Income taxes | 67/77 | €544k |
| Net result for the period | 9904 | €5.46M |
| Result to be appropriated | 9905 | €5.46M |
| NACE primary | Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies(70200) |
| Legal form | Private limited company(610) |
| Incorporation | 05-07-2004 |
| Status | Active |
| Postal code | 1910 |
Each band states what its claims rest on. A board seat is influence over the board, not ownership. Court mandates (receiver, interim administrator) and liquidation mandates do not link companies and are therefore absent here; they belong under Directors & mandates.
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23038B0344/00G000 | Flanders | 2,120 m² | 1 · 39 m² | 10.0 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
08-06-2026 General meeting · Notarial deed · Auditor waiver · Auditor report
- Filing: 2026-05-28 · COLE PHARMACEUTICALS
- Publication: 2026-06-08 · COLE PHARMACEUTICALS
- General meeting: 2025-12-23 · COLE PHARMACEUTICALS
- Notarial deed: 2025-12-23 · COLE PHARMACEUTICALS
- Auditor waiver · COLE PHARMACEUTICALS
- Auditor report · COLE PHARMACEUTICALS
- Approval · COLE PHARMACEUTICALS
- Capital increase: amount: 1589000, currency: EUR, share_class: D, share_premium: 0, shares_issued: 659549 · COLE PHARMACEUTICALS
- Share distribution: class: D, shares: 35088 · COLE PHARMACEUTICALS
- Share distribution: class: D, shares: 2105 · COLE PHARMACEUTICALS
- Share distribution: class: D, shares: 92184 · COLE PHARMACEUTICALS
- Share distribution: class: D, shares: 90113 · COLE PHARMACEUTICALS
- Share distribution: class: D, shares: 60172 · COLE PHARMACEUTICALS
- Share distribution: class: D, shares: 111586 · COLE PHARMACEUTICALS
- Share distribution: class: D, shares: 268301 · COLE PHARMACEUTICALS
- Statute amendment · COLE PHARMACEUTICALS
- Governance rule · COLE PHARMACEUTICALS
- Reserve release · COLE PHARMACEUTICALS
- Act object: Apports en nature - Modification des statuts
Technical details
{
"facts": [
{
"type": "filing",
"quote": "TRIBUNAL DE L\u0027ENTREPRISE 28 MAI 2026",
"value": "2026-05-28",
"object": null,
"subject": "e1"
},
{
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 08/06/2026 - Annexes du Moniteur belge",
"value": "2026-06-08",
"object": null,
"subject": "e1"
},
{
"type": "general_meeting",
"quote": "D\u0027un proc\u00E8s-verbal d\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire dress\u00E9 par le notaire Laurent WETS, \u00E0 Uccle, le 23 d\u00E9cembre 2025",
"value": "2025-12-23",
"object": null,
"subject": "e1"
},
{
"type": "notarial_deed",
"quote": "D\u0027un proc\u00E8s-verbal d\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire dress\u00E9 par le notaire Laurent WETS, \u00E0 Uccle, le 23 d\u00E9cembre 2025",
"value": "2025-12-23",
"object": "e2",
"subject": "e1"
},
{
"type": "auditor_waiver",
"quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale a dispens\u00E9 le Pr\u00E9sident de donner lecture du rapport \u00E9tabli par l\u0027organe d\u0027administration, le 15 d\u00E9cembre 2025",
"value": null,
"object": null,
"subject": "e1"
},
{
"type": "auditor_report",
"quote": "Le rapport du R\u00E9viseur d\u0027entreprises, Monsieur DEMONCEAU David, exer\u00E7ant sa fonction dans la Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e \u003C AXYLIUM AUDIT - LIEGE \u00BB",
"value": null,
"object": "e4",
"subject": "e1"
},
{
"type": "approval",
"quote": "L\u0027assembl\u00E9e a approuv\u00E9 ces deux rapports.",
"value": null,
"object": null,
"subject": "e1"
},
{
"type": "capital_increase",
"quote": "L\u0027op\u00E9ration consiste en une augmentation des capitaux propres de 1.589.000 \u20AC par apports de cr\u00E9ances et de droits de propri\u00E9t\u00E9 intellectuelle",
"value": {
"amount": 1589000,
"currency": "EUR",
"share_class": "D",
"share_premium": 0,
"shares_issued": 659549
},
"object": null,
"subject": "e1"
},
{
"type": "share_distribution",
"quote": "1. A La Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e \u003C Sodintec Finances \u00BB, pr\u00E9cit\u00E9e, qui a d\u00E9clar\u00E9 accepter, trente-cing mille quatre-vingt-huit actions, ci: 35.088",
"value": {
"class": "D",
"shares": 35088,
"consideration": {
"type": "cr\u00E9ances",
"amount": 60000,
"currency": "EUR"
}
},
"object": "e6",
"subject": "e1"
},
{
"type": "share_distribution",
"quote": "2. A La Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e \u00AB Spreds Finance \u003E, qui a d\u00E9clar\u00E9 accepter, deux mille cent cing cents actions, ci: 2.105",
"value": {
"class": "D",
"shares": 2105,
"consideration": {
"type": "cr\u00E9ances",
"amount": 4760,
"currency": "EUR"
}
},
"object": "e7",
"subject": "e1"
},
{
"type": "share_distribution",
"quote": "3. A la Soci\u00E9t\u00E9 Anonyme \u003C C\u0026N Holding \u00BB, pr\u00E9cit\u00E9e, qui a d\u00E9clar\u00E9 accepter, nonante-deux mille cent quatre-vingt-quatre actions, ci: 92.184",
"value": {
"class": "D",
"shares": 92184,
"consideration": {
"type": "cr\u00E9ances",
"amount": 200000,
"currency": "EUR"
}
},
"object": "e8",
"subject": "e1"
},
{
"type": "share_distribution",
"quote": "4. A Monsieur DELEUZE St\u00E9phane, pr\u00E9nomm\u00E9, qui a d\u00E9clar\u00E9 accepter, nonante mille cent treize actions, ci : 90.113",
"value": {
"class": "D",
"shares": 90113,
"consideration": {
"type": "cr\u00E9ances",
"amount": 200000,
"currency": "EUR"
}
},
"object": "e9",
"subject": "e1"
},
{
"type": "share_distribution",
"quote": "5. A Monsieur B\u00C9NARD Andr\u00E9, pr\u00E9nomm\u00E9, qui a d\u00E9clar\u00E9 accepter, soixante mille cent soixante-deux actions, ci: 60.172",
"value": {
"class": "D",
"shares": 60172,
"consideration": {
"type": "cr\u00E9ances",
"amount": 150000,
"currency": "EUR"
}
},
"object": "e10",
"subject": "e1"
},
{
"type": "share_distribution",
"quote": "6. A Monsieur PHILIPS Mario, pr\u00E9nomm\u00E9, qui a d\u00E9clar\u00E9 accepter, cent onze mille cing cent quatre-vingt-six (111.586) actions, ci: 111.586",
"value": {
"class": "D",
"shares": 111586,
"consideration": {
"type": "cr\u00E9ances",
"amount": 200000,
"currency": "EUR"
}
},
"object": "e11",
"subject": "e1"
},
{
"type": "share_distribution",
"quote": "7. A la Soci\u00E9t\u00E9 Anonyme Phytomed, pr\u00E9cit\u00E9e, qui a d\u00E9clar\u00E9 accepter, deux cent soixante-huit mille trois cent une actions, ci: 268.301",
"value": {
"class": "D",
"shares": 268301,
"consideration": {
"type": "droits de propri\u00E9t\u00E9 intellectuelle",
"amount": 775000,
"currency": "EUR"
}
},
"object": "e12",
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "l\u0027assembl\u00E9e g\u00E9n\u00E9rale a d\u00E9clar\u00E9 et d\u00E9cid\u00E9 de remplacer les articles 5, 7 et 11 des statuts par les textes suivants",
"value": null,
"object": null,
"subject": "e1"
},
{
"type": "governance_rule",
"quote": "l\u0027assembl\u00E9e g\u00E9n\u00E9rale a d\u00E9cid\u00E9 de pr\u00E9voir, dans les statuts, la d\u00E9l\u00E9gation \u00E0 l\u0027organe d\u0027administration du pouvoir de proc\u00E9der, dans les limites des articles 5:142 et 5:143 dudit Code \u00E0 des distributions provenant du b\u00E9n\u00E9fice de l\u0027exercice en cours ou du b\u00E9n\u00E9fice de l\u0027exercice pr\u00E9c\u00E9dent tant que les comptes annuels de cet exercice n\u0027ont pas \u00E9t\u00E9 approuv\u00E9s",
"value": null,
"object": null,
"subject": "e1"
},
{
"type": "reserve_release",
"quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale a d\u00E9cid\u00E9 de transf\u00E9rer la totalit\u00E9 des pertes report\u00E9es au compte apports disponibles.",
"value": null,
"object": null,
"subject": "e1"
},
{
"type": "act_object",
"quote": "Objet de l\u0027acte: Apports en nature - Modification des statuts",
"value": "Apports en nature - Modification des statuts",
"object": null,
"subject": null
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 18831,
"truncated": false,
"needs_verify": true
},
"entities": [
{
"id": "e1",
"kbo": "0671.904.152",
"kind": "company",
"name": "COLE PHARMACEUTICALS",
"attrs": {
"vat": "BE0671.904.152",
"seat": "1435 Mont-Saint-Guibert, Rue Andr\u00E9 Dumont, 7",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e",
"short_name": "Cole Pharma"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Laurent WETS",
"attrs": {
"role": "notaire"
}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "V\u00E9ronique Bonehill",
"attrs": {
"role": "notaire"
}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "DEMONCEAU David",
"attrs": {
"role": "R\u00E9viseur d\u0027entreprises"
}
},
{
"id": "e5",
"kbo": null,
"kind": "org",
"name": "AXYLIUM AUDIT - LIEGE",
"attrs": {
"legal_form": "Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e"
}
},
{
"id": "e6",
"kbo": "0507.657.517",
"kind": "company",
"name": "Sodintec Finances",
"attrs": {
"vat": "BE0507.657.517",
"seat": "1200 Woluwe-Saint-Lambert Bruxelles, Rue Lola Bobesco, 2, bo\u00EEte 13",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e"
}
},
{
"id": "e7",
"kbo": "0538.839.354",
"kind": "company",
"name": "Spreds Finance",
"attrs": {
"vat": "BE0538.839.354",
"seat": "1000 Bruxelles, Rue des Colonies, 11",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e"
}
},
{
"id": "e8",
"kbo": "0866.337.880",
"kind": "company",
"name": "C\u0026N Holding",
"attrs": {
"vat": "BE0866.337.880",
"seat": "1910 Kampenhout, Terloonststraat, 22",
"legal_form": "Soci\u00E9t\u00E9 Anonyme"
}
},
{
"id": "e9",
"kbo": null,
"kind": "person",
"name": "DELEUZE St\u00E9phane Camille Paul Arthur",
"attrs": {
"domicile": "London (Royaume-Uni-Grande Bretagne), Lawn Lane, 10, Apartment 1"
}
},
{
"id": "e10",
"kbo": null,
"kind": "person",
"name": "B\u00C9NARD Andr\u00E9 Marcel Victor",
"attrs": {
"domicile": "Woluwe-Saint-Pierre (1150 Bruxelles), Avenue des Cormorans, 38"
}
},
{
"id": "e11",
"kbo": null,
"kind": "person",
"name": "PHILIPS Mario",
"attrs": {
"domicile": "9340 Lede, Erfken, 6"
}
},
{
"id": "e12",
"kbo": "1031.897.777",
"kind": "company",
"name": "Phytomed",
"attrs": {
"vat": "BE 1031.897.777",
"seat": "9911 Troisvierges (Grand-Duch\u00E9 du Luxembourg), Rue de Drinklange, 2",
"rcs_lux": "B184202",
"legal_form": "Soci\u00E9t\u00E9 Anonyme de droit luxembourgeois"
}
}
]
}14-04-2026 Act object · General meeting · Officer resignation · Officer discharge
- Filing: 2026-04-07 · Ter Loonst
- Act object: Uittreksel uit Bijzondere algemene vergadering van 26-02-2026 · Ter Loonst
- General meeting: date: 2026-02-26, type: Bijzondere algemene vergadering · Ter Loonst
- Officer resignation: date: 2026-02-26, role: bestuurder · Nico Swinnen
- Officer discharge · Nico Swinnen
- Officer appointment: date: 2026-02-26, role: bestuurder, duration: onbepaalde duur · C&N Holding
- Permanent representative: role: vaste vertegenwoordiger, legal_basis: artikel 61 § 2 van het Wetboek van Vennootschappen · Nico Swinnen
- Mandate compensation: onbezoldigd · C&N Holding
- Publication: 2026-04-14
Technical details
{
"facts": [
{
"type": "filing",
"quote": "na neerlegojng van.de akte ter ariffie 07 APR. 2026",
"value": "2026-04-07",
"object": null,
"subject": "e1"
},
{
"type": "act_object",
"quote": "Onderwerp akte : Uittreksel uit Bijzondere algemene vergadering van 26-02-2026",
"value": "Uittreksel uit Bijzondere algemene vergadering van 26-02-2026",
"object": null,
"subject": "e1"
},
{
"type": "general_meeting",
"quote": "Uittreksel uit Bijzondere algemene vergadering van 26-02-2026",
"value": {
"date": "2026-02-26",
"type": "Bijzondere algemene vergadering"
},
"object": null,
"subject": "e1"
},
{
"type": "officer_resignation",
"quote": "De bijzondere algemene vergadering beslist met ingang van 26-02-2026 een einde te stellen aan het mandaat van bestuurder Nico Swinnen.",
"value": {
"date": "2026-02-26",
"role": "bestuurder"
},
"object": "e1",
"subject": "e2"
},
{
"type": "officer_discharge",
"quote": "De bijzondere algemene vergadering geeft kwijting aan de bestuurder voor het uitgeoefende mandaat.",
"value": null,
"object": "e1",
"subject": "e2"
},
{
"type": "officer_appointment",
"quote": "De vergadering beslist als nieuwe bestuurder te benoemen: C\u0026N Holding ... Het mandaat gaat in op 26-02-2026 en is van onbepaalde duur.",
"value": {
"date": "2026-02-26",
"role": "bestuurder",
"duration": "onbepaalde duur"
},
"object": "e1",
"subject": "e3"
},
{
"type": "permanent_representative",
"quote": "Voor deze vennootschap zal Nico Swinnen wonende te Terloonststraat 22, 1910 Kampenhout optreden als vaste vertegenwoordiger in de zin van artikel 61 \u00A7 2 van het Wetboek van Vennootschappen.",
"value": {
"role": "vaste vertegenwoordiger",
"legal_basis": "artikel 61 \u00A7 2 van het Wetboek van Vennootschappen"
},
"object": "e3",
"subject": "e2"
},
{
"type": "mandate_compensation",
"quote": "Het mandaat van de zopas benoemde bestuurder is onbezoldigd.",
"value": "onbezoldigd",
"object": "e1",
"subject": "e3"
},
{
"type": "publication",
"quote": "Belgisch Staatsblad - 14/04/2026",
"value": "2026-04-14",
"object": null,
"subject": null
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 2027,
"truncated": false,
"needs_verify": false
},
"entities": [
{
"id": "e1",
"kbo": "0536.854.616",
"kind": "company",
"name": "Ter Loonst",
"attrs": {
"address": "Terloonststraat 22, 1910 Kampenhout",
"legal_form": "BV",
"short_name": "HTL"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Nico Swinnen",
"attrs": {
"address": "Terloonststraat 22, 1910 Kampenhout"
}
},
{
"id": "e3",
"kbo": "0866.337.880",
"kind": "company",
"name": "C\u0026N Holding",
"attrs": {
"address": "Terloonststraat 22, 1910 Kampenhout"
}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Caroline Steensels",
"attrs": {}
}
]
}19-06-2024 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": "completed",
"notary": {
"name": "Samu\u00EBl Van der Linden",
"firm_city": null,
"firm_name": null,
"office_city": "Diepenbeek",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-06-19",
"filing_date": "2024-06-15",
"act_kind_objet": "STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN), DOEL, WIJZIGING RECHTSVORM, KAPITAAL, AANDELEN, ONTSLAGEN, BENOEMINGEN, DIVERSEN"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-06-11",
"unanimous": null
},
"conversion": {
"effective_date": "2024-01-01",
"jurisdiction_to": null,
"legal_form_after": "B.V.",
"jurisdiction_from": null,
"legal_form_before": "B.V."
},
"detected_kind": "conversion_legal_form",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0866.337.880",
"name": "C\u0026N Holding",
"role": "contributor",
"address": "Terloonststraat 22, 1910 Kampenhout",
"is_foreign": false,
"legal_form": "B.V.",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": null,
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0866.337.880",
"name_full": "C\u0026N HOLDING",
"legal_form": "B.V."
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Samu\u00EBl Van der Linden",
"org_rep_person_name": null
},
"summary_narrative": "De algemene vergadering van C\u0026N Holding heeft een reeks beslissingen genomen, waaronder de omzetting van de vennootschap in een besloten vennootschap met beperkte aansprakelijkheid, wijzigingen in de statuten, het doel, het kapitaal en de aandelen, en het ontslag en benoeming van bestuurders.",
"co_filed_documents": [
"Expeditie van het proces-verbaal, geco\u00F6rdineerde statuten."
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": null
}| Legal nameNL | C&N HOLDING |